RF33 | PSAT68 Gonadotropin-Releasing Hormone Agonist Therapy Does Not Affect Bone Mineral Density in Congenital Adrenal Hyperplasia: a Clinical Study

BACKGROUND: Children with congenital adrenal hyperplasia (CAH) are at risk for early central puberty, and gonadotropin-releasing hormone analogs (GnRHa) are frequently used aiming to improve adult height. However, their effect on bone health among the CAH population has not been previously studied....

Descripción completa

Detalles Bibliográficos
Autores principales: Flokas, Myrto, Kollender, Sarah, Wakim, Paul, Sinaii, Ninet, Parker, Megan, Mallappa, Ashwini, Merke, Deborah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Adrenal
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624733/
http://dx.doi.org/10.1210/jendso/bvac150.285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624733/
http://dx.doi.org/10.1210/jendso/bvac150.285

Ejemplares similares